![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1453944
¼¼°èÀÇ ÀÇ·á¿ë ÀÇ·ù ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®Medical Clothing Market Forecasts to 2030 - Global Analysis By Product, Usage, Distribution Channel, Application, End User and by Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°è ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀº 2023³â 1,071¾ï 2,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, 2030³â¿¡´Â 2,100¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. û°á, ¾ÈÀü ¹× ¹«±Õ ÀÇ·á ȯ°æÀº ÀÇ·á ÀÇ·ù¸¦ »ç¿ëÇÏ¿© Å©°Ô Çâ»óµË´Ï´Ù. ÀÇ·á¿ë ÀÇ·ùÀº ±â´É°ú Á¤È®¼ºÀ» ¿°µÎ¿¡µÎ°í ¸¸µé¾îÁý´Ï´Ù. ¿©±â¿¡´Â ½ºÅ©·´, ¹éÀÇ, ¼ö¼úº¹, º¸È£ Ä¿¹ö µî ´Ù¾çÇÑ ÀǺ¹ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ÀǺ¹Àº ¾ö°ÝÇÑ À§»ý ÁöħÀ» ÁؼöÇÏ¿© ¸¸µé¾îÁ® ºÒ¼ø¹°·ÎºÎÅÍ º¸È£ÇÏ°í °¨¿°ÀÇ È®»ê °¡´É¼ºÀ» ÁÙÀÔ´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é °¡¸éÀ̳ª °¡¿î µî ÀÇ·á¿ë ÀÇ·ù¸¦ Æ÷ÇÔÇÑ °³ÀÎ ¹æÈ£±¸¸¦ ÀûÀýÈ÷ »ç¿ëÇÏ´Â °ÍÀº ÀÇ·á Á¾»çÀÚÀÇ ¾ÈÀüÀ» Áö۰í ÀÇ·á ÇöÀå¿¡¼ °¨¿°ÀÇ ¸¸¿¬À» ¸·±â À§ÇØ °¡Àå Áß¿ä ÀÔ´Ï´Ù.
ÀÇ·á °ü·Ã °¨¿°(HAI)¿¡ ´ëÇÑ Áö½Ä Çâ»ó
ÀÇ·á °ü·Ã °¨¿°(HAI)¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡´Â ÀÇ·á ÀÇ·ù »ê¾÷À» µÞ¹ÞħÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÇ·á Á¾»çÀÚ¿Í ÀÇ·á ±â°üÀº °¨¿° ÅëÁ¦¿Í ¿¹¹æ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀÌ°í ¹«±Õ ÀÇ·á ȯ°æÀ» À¯ÁöÇϱâ À§ÇÑ Æ¯¼ö ÀÇ·á ÀǺ¹ÀÇ Á߿伺À» ¾Ë°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÇöÀå¿¡¼ÀÇ °¨¿° È®´ë¸¦ ¾ïÁ¦Çϱâ À§ÇØ ¸¸µé¾îÁø °í±Þ º¸È£º¹¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ÀÌ·¯ÇÑ ÀǽÄÀÇ °á°úÀÔ´Ï´Ù.
Áö¼Ó°¡´É¼º°ú ȯ°æ¹®Á¦
ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀÇ »õ·Î¿î Á¦¾à Áß Çϳª´Â ȯ°æÀÇ Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡ÀÔ´Ï´Ù. ±âÁ¸ÀÇ ÀÇ·á¿ë ÀÇ·ù »ý»ê¿¡ »ç¿ëµÈ Àç·á¿Í Á¦Á¶ ±â¼úÀº ȯ°æ ¾Çȸ¦ ¾ÇȽÃų ¼ö ÀÖ½À´Ï´Ù. ¾÷°è´Â ģȯ°æ »ý»ê ±â¼ú°ú ģȯ°æ ¼¶À¯ÀÇ µµÀÔÀ» °¿äÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶¾÷ü´Â ÀÇ·á¿ë ÀÇ·ù ¼ö¿ä¿Í ȯ°æ Ä£ÈÀûÀÎ ½ÇõÀ» ¾ç¸³½ÃŰ´Â ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ ½ÃÀåÀÇ Àå±âÀûÀÎ Á¸¼Ó¿¡ ÇʼöÀûÀÔ´Ï´Ù.
½º¸¶Æ® ¼¶À¯ÀÇ ±â¼ú Áøº¸
ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀº ½º¸¶Æ® ¼¶À¯ÀÇ Áö¼ÓÀûÀÎ Áøº¸·Î »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ç·Á°íÇÕ´Ï´Ù. ÀÇ·á¿ë ÀÇ·ù´Â ¼¾¼, ¿Âµµ Á¶Àý ¼¶À¯, ¸ð´ÏÅ͸µ Àåºñ µîÀÇ ±â¼úÀ» µµÀÔÇÏ¿© º¸´Ù ¿ì¼öÇÑ ±â´ÉÀ» ¹ßÈÖÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ °Ç° ¸ð´ÏÅ͸µÀº ½º¸¶Æ® ÅØ½ºÅ¸ÀÏ·Î °¡´ÉÇϸç ȯÀÚ Äɾ °³¼±Çϰí ÀÇ·á Àü¹®°¡¿¡°Ô À¯¿ëÇÑ Á¤º¸¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼ú°ú ÀÇ·á¿ë ÀÇ·ùÀÇ À¶ÇÕÀº Çõ½Å°ú ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
¼¼°è °ø±Þ¸ÁÀÇ °Ýº¯
¼¼°è °ø±Þ¸ÁÀÇ È¥¶õÀº À¯Çà, ÀÚ¿¬ÀçÇØ, ÁöÁ¤ÇÐÀû ºÒ¾È µî ´Ù¾çÇÑ »çÅ·ΠÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç ÀÇ·á¿ë ÀÇ·ù ½ÃÀå¿¡ À§ÇùÀ» °¡Çϰí ÀÖ½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀº Á¦Á¶ ºñ¿ë »ó½Â, »ý»ê Áö¿¬, ¿øÀç·á ºÎÁ·À» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á¿ë ÀÇ·ù ºÎ¹®¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ±â¾÷ÀÇ °æ¿ì °ß°íÇÑ °ø±Þ¸ÁÀ» ±¸ÃàÇϰí Á¶´Þ Àü·«À» ´Ù¾çÈÇÏ´Â °ÍÀº ÀáÀçÀûÀΠȥ¶õÀ» ¿ÏÈÇϰí ÇʼöÀûÀÎ ¿ø·áÀÇ ¾ÈÁ¤ÀûÀÎ °ø±ÞÀ» À¯ÁöÇϱâ À§ÇØ ¿¡ ÇʼöÀûÀÔ´Ï´Ù.
ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀº COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÏ¹Ý ½Ã¹Î°ú ÀÇ·á Á¾»çÀÚ¸¦ º¸È£Çϱâ À§ÇÑ °³Àκ¸È£±¸(PPE)(PPE)¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀåÀº Àü·Ê ¾ø´Â ±â¼¼·Î ¼ºÀåÇß½À´Ï´Ù. °¨¿° ÅëÁ¦ ½Çõ¿¡ ´ëÇÑ ÀǽÄÀº Àå°©, °¡¿î, ¸¶½ºÅ© µî ÀÇ·á¿ë ÀÇ·ùÀÇ Á¦Á¶¿Í »ç¿ëÀÌ Å©°Ô Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ °ø±Þ¸Á È¥¶õ, ºÒ¾ÈÁ¤ÇÑ ¿øÀç·á °¡°Ý, ¾ö°ÝÇÑ ±ÔÁ¦·Î ÀÎÇØ Á¦Á¶¾÷ü´Â °æ¿µ ¹®Á¦¿¡ Á÷¸é ÇØ ÀÖ½À´Ï´Ù.
¼ö¼ú¿ë µå·¹ÀÌÇÁ, ½ºÅ©·´, °¡¿î ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë°¡ µÉ Àü¸Á
ÀÇ·á¿ë ÀÇ·ù ½ÃÀå¿¡¼´Â ¼ö¼ú¿ë µå·¹ÀÌÇÁ, ½ºÅ©·´, °¡¿îÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ½ºÅ©·´°ú °¡¿îÀº ÀÇ·á Á¾»çÀÚ¿¡°Ô ÇʼöÀûÀÎ º¸È£ º¹À̸ç, ¼ö¼ú¿ë µå·¹ÀÌÇÁ´Â Ä¡·á Áß¿¡ ¹«±Õ Çʵ带 ¸¸µé°í ¿À¿°À» ¹æÁöÇÕ´Ï´Ù. ÀÌ ½ÃÀå ºÎ¹®ÀÇ ÀÌÁ¡Àº ¼ö¼úÀÇ ²÷ÀÓ¾ø´Â Çʿ伺, °¨¿° ÅëÁ¦ ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ ¼¼°èÀÇ ÁÖ¸ñ, ÀÇ·á ½Ã¼³¿¡¼ ¼öÇàµÇ´Â ¼ö¼ú °Ç¼ö Áõ°¡·Î À̾îÁý´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº °¡Á¤ ÀÇ·á ºÎ¹®ÀÔ´Ï´Ù.
ÀÇ·á¿ë ÀÇ·ù ½ÃÀå¿¡¼´Â °¡Á¤ ÀÇ·á ºÎ¹®ÀÌ °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á ¼ºñ½ºÀÇ µ¿ÇâÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ÀçÅà Äɾî ȯ°æ¿¡¼ÀÇ »ç¿ëÀ» ¸ñÀûÀ¸·Î ÇÑ ÀÇ·á¿ë ÀÇ·ù¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ȯÀÚ¿ë ÀǺ¹À̳ª °£º´ÀÎ¿ë º¸È£º¹ µîÀÇ Æ¯¼öÇÑ ÀǺ¹Àº ÄèÀûÇÑ Áý¿¡¼ ÀǷḦ ¹Þ´Â ȯÀÚ°¡ ´Ã¾î³²¿¡ µû¶ó Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·áÀÇ Çʿ伺, ¿ø°Ý ÀÇ·áÀÇ Áøº¸, °í·ÉȰ¡ ÀçÅà ÄɾÀÇ ½ÃÇÁÆ®ÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀº ºÏ¹Ì°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÌ ¿ìÀ§¸¦ Â÷ÁöÇÏ´Â ¿äÀÎÀ¸·Î´Â °·ÂÇÑ ±ÔÁ¦, Á¤ºñµÈ ÀÇ·á ½Ã½ºÅÛ, °¨¿° ´ëÃ¥¿¡ ´ëÇÑ ³ôÀº ÀǽÄÀ» µé ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ºÏ¹Ì°¡ ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ÁÖ¿ä ÈûÀÌ µÇ°í ÀÖ´Ù´Â ±â·ÏÀº ÀÇ·á¿ë ¼¶À¯ÀÇ ½Å±â¼ú°ú Çõ½ÅÀÇ Àû±ØÀûÀÎ ¼ö¿ë°ú ÀÇ·á Á¾»çÀÚÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ °ü½ÉÀÇ ³ô¾ÆÁü¿¡ ÀÇÇØ È®°íÇÏ´Ù ¹°°ÇÀÔ´Ï´Ù.
ÀÇ·á¿ë ÀÇ·ù ½ÃÀåÀº ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼ °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù. ÀÇ·á¿ë ÀÇ·ùÀÇ ¿ä±¸´Â Àα¸ Áõ°¡, ÀÇ·áºñ »ó½Â, °¨¿°Áõ ´ëÃ¥¿¡ÀÇ ÀǽÄÀÇ °íÁ¶ µî, ÀÌ Áö¿ªÀÇ ÀÇ·á ȯ°æÀÇ º¯È°¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °·ÂÇÑ ¼ºÀåÀº ƯÈ÷ Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡¿¡¼ÀÇ ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü, ¼ö¼ú Áõ°¡, À§»ý ±âÁØÀÇ Á߿伺 Áõ°¡ µî ¸¹Àº ¿äÀε鿡 ÀÇÇØ ¾ß±âµÇ°í ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Medical Clothing Market is accounted for $107.12 billion in 2023 and is expected to reach $210.07 billion by 2030 growing at a CAGR of 10.1% during the forecast period. A clean, safe, and sterile healthcare environment is greatly enhanced by the use of medical clothing. Medical clothing is made with function and accuracy in mind. It includes a variety of clothes like scrubs, lab coats, surgical gowns, and protective coverings. These clothes are made to adhere to strict hygienic guidelines, offering protection from impurities and reducing the chance of infection spreading.
According to the World Health Organization (WHO), proper utilization of personal protective equipment, including medical clothing such as masks and gowns, is paramount to safeguarding healthcare workers and preventing the spread of infectious diseases in healthcare settings.
Raising knowledge of infections associated with healthcare (HAIs)
The growing consciousness regarding healthcare-associated infections (HAIs) is a key factor propelling the medical apparel industry. Healthcare practitioners and institutions are realizing the importance of specialized medical clothing in lowering the risk of cross-contamination and maintaining a sterile healthcare environment as there is a growing focus on infection control and prevention. Furthermore, the increased demand for premium, protective clothing made to reduce the spread of infections in healthcare settings is a result of this awareness.
Sustainability and environmental issues
One emerging constraint in the medical clothing market is the growing consciousness of environmental sustainability. The materials and manufacturing techniques used in traditional medical apparel production may exacerbate environmental degradation. The industry is under pressure to implement more environmentally friendly production techniques and eco-friendly textiles. Additionally, manufacturers face a challenge in juggling the demands of medical apparel with environmentally friendly practices, and resolving these issues is essential to the market's long-term viability.
Technological progress in smart textiles
The medical clothing market is poised for substantial growth due to the continuous progress in smart textiles. Medical apparel can function better when it incorporates technology, such as sensors, temperature-regulating textiles, and monitoring equipment. Real-time health monitoring is made possible by smart textiles, which could improve patient care and give medical professionals useful information. Moreover, the convergence of technology and medical apparel presents novel opportunities for innovation and market growth.
Worldwide supply chain upheavals
Global supply chain disruptions, which can be brought on by a number of things, including pandemics, natural disasters, and geopolitical unrest, pose a threat to the medical apparel market. Supply chain disruptions can result in higher manufacturing costs, production delays, and shortages of raw materials. Additionally, establishing robust supply chains and diversifying sourcing strategies are imperative for companies operating in the medical clothing sector to mitigate potential disruptions and maintain a consistent supply of essential materials.
The market for medical apparel has been significantly impacted by the COVID-19 pandemic. The market has grown at an unprecedented rate due to the rise in demand for personal protective equipment (PPE) to protect the public and healthcare workers. Awareness of infection control practices has resulted in a significant increase in the manufacture and use of medical apparel, such as gloves, gowns, and masks. Furthermore, manufacturers have faced operational challenges due to supply chain disruptions, volatile raw material prices, and strict regulations.
The Surgical Drapes, Scrubs and Gowns segment is expected to be the largest during the forecast period
In the medical clothing market, surgical drapes, scrubs, and gowns hold the largest market share. Scrubs and gowns are vital protective apparel for medical personnel, and surgical drapes create a sterile field during procedures to prevent contamination. This market segment's dominance is driven by the constant need for surgical interventions, the worldwide focus on infection control protocols, and the rising number of surgeries performed in healthcare facilities.
The Home Care Settings segment is expected to have the highest CAGR during the forecast period
The home care settings segment in the medical clothing market is growing at the highest CAGR. Medical apparel intended for use in home care settings is in high demand due to the growing trend toward home healthcare services. Specialized clothing, such as patient apparel and protective gear for caregivers, is becoming more and more necessary as more patients receive medical care in the comfort of their own homes. Additionally, the need for individualized healthcare, telemedicine advancements, and the aging population are the main drivers of the shift towards home care.
The market for medical clothing worldwide is anticipated to hold the largest share in North America. Strong regulations, a strong regulatory framework, a well-established healthcare system, and a high level of awareness of infection control practices are all considered contributing factors to the region's dominance. Furthermore, North America's record of being a major force behind the growth of the medical clothing market is cemented by the region's aggressive embrace of new technologies and innovations in medical textiles, as well as the growing focus on the safety of healthcare workers.
The medical clothing market is expected to grow at the highest CAGR in the Asia-Pacific region. The need for medical clothes is being driven by the region's changing healthcare environment, which is characterized by a growing population, rising healthcare costs, and growing awareness of infection control measures. Moreover, the strong growth in Asia-Pacific is caused by a number of factors, including the development of the region's healthcare infrastructure, especially in nations like China and India, the rise in surgical operations, and the increased emphasis on hygienic standards.
Key players in the market
Some of the key players in Medical Clothing market include DuPont de Nemours Inc., B. Braun Melsungen AG, Henry Schein, Inc., 3M Company, Smith+Nephew, Carhartt, Inc, Medline Industries, Inc., Barco Uniforms, Johnson & Johnson, Molnlycke Health Care AB, Ansell Healthcare LLC, Owens & Minor, Inc., Semperit AG Holding, Cardinal Health, Inc., Stryker Corporation, LynkTrac Technologies LLC, Narang Medical Limited and Halyard Health.
In August 2023, DuPont announced a definitive agreement to sell an 80.1% ownership interest in the Delrin(R) acetal homopolymer (H-POM) business1 to TJC LP (TJC) in a transaction valuing the business at $1.8 billion. TJC has received fully committed financing in connection with the transaction, which is expected to close around year-end 2023, subject to customary closing conditions and regulatory approval.
In May 2023, Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental and medical practitioners, announced an agreement to acquire S.I.N. Implant System, one of Brazil's leading manufacturers of dental implants, pending regulatory approval. Henry Schein will acquire S.I.N. from the Southern Cross Group, one of the largest independent private equity fund managers focused on Latin America. The transaction is subject to approval by Brazil's Administrative Council for Economic Defense and is expected to close in the latter half of 2023.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.